Mar 28, 2022 / 08:30PM GMT
Presentation
Mar 28, 2022 / 08:30PM GMT
=====================
Corporate Participants
=====================
* Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development
* Jason Kelly
Ginkgo Bioworks Holdings, Inc. - Co-Founder, CEO & Director
* Mark E. Dmytruk
Ginkgo Bioworks Holdings, Inc. - CFO
=====================
Conference Call Participants
=====================
* Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
* Mark Anthony Massaro
BTIG, LLC, Research Division - MD & Life Science & Diagnostic Tools Analyst
* Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Matthew Richard Larew
William Blair & Company L.L.C., Research Division - Research Analyst
* Poon Mah
Cowen and Company, LLC, Research Division - Senior Analyst
* Rahul Sarugaser
Raymond James Ltd., Research Division - MD and Equity Analyst of Healthcare, Biotechnology & Cannabis
Ginkgo Bioworks Holdings Inc
(MEX:DNA)
MXN
173.2
0 (0%)
Market Cap: 8.89 Bil
Enterprise Value: 3.43 Bil
PE Ratio: 0
PB Ratio: 0.50
GF Score: 26/100 Q4 2021 Ginkgo Bioworks Holdings Inc Earnings Presentation Transcript
Mar 28, 2022 / 08:30PM GMT
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot